transferred and merged with the Infectious Diseases Rapid Response Reserve Fund established by section 231 of division B of Public Law 115–245 . (8) All of the unobligated balances of funds made available under the heading Centers for Disease Control and Prevention—CDC–Wide Activities and Program Support in title VIII of division B of Public Law 116–136 , including any funds transferred from such heading that remain unobligated, with the exception of $446,000,000 and any funds that were transferred and merged with the Infectious Diseases Rapid Response Reserve Fund established by section 231 of division B of Public Law 115–245 . (9) All of the unobligated balances of funds made available under the heading Centers for Disease Control and Prevention—CDC–Wide Activities and Program Support in title III of division M of Public Law 116–260 , including any funds transferred from such heading that remain unobligated, with the exception of $177,000,000. (10) All of the unobligated balances of funds made available under the heading National Institutes of Health—National Institute of Allergy and Infectious Diseases in title III of division A of Public Law 116–123 , including any funds transferred from such heading that remain unobligated. (11) All of the unobligated balances of funds made available to Centers for Medicare & Medicaid Services—Program Management in title VIII of division B of Public Law 116–136 . (12) All of the unobligated balances of funds made available by section 2301 of Public Law 117–2 , with the exception of $103,000,000. (13) All of the unobligated balances of funds made available by section 2302 of Public Law 117–2 . (14) All of the unobligated balances of funds made available by section 2303 of Public Law 117–2 , with the exception of $69,000,000. (15) All of the unobligated balances of funds made available by section 2401 of Public Law 117–2 , with the exception of $7,323,000,000. (16) All of the unobligated balances of funds made available by section 2402 of Public Law 117–2 , with the exception